Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

Clinical trial NCT06315309 · RECRUITING

Trial details

NCT number: NCT06315309
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

GVHD,Acute Acute Leukemia Myelodysplastic Syndromes Myeloproliferative Disorders

Start date: 2025-04-15
Primary completion: 2026-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.